Digestive system mixed adenoneuroendocrine carcinoma

Summary

Digestive system mixed adenoneuroendocrine carcinoma (MONDO:0006182) is a cancer. A subtype of digestive system carcinoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	digestive system mixed adenoneuroendocrine carcinoma
Mondo ID	MONDO:0006182
EFO	EFO:1000219
NCIT	C95406
UMLS	C2987129
MedGen	459355
Is cancer (heuristic)	yes

Also known as: digestive system Mixed Adenoneuroendocrine cancer · digestive system mixed adenoneuroendocrine carcinoma · gastrointestinal MANEC · gastrointestinal mixed Adenoneuroendocrine carcinoma · MANEC · mixed Adenoneuroendocrine carcinoma

Disease family

This is a subtype of digestive system carcinoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › digestive system disorder › digestive system cancer › digestive system carcinoma › digestive system mixed adenoneuroendocrine carcinoma

Related subtypes (15): maxillary sinus carcinoma, gastroesophageal junction adenocarcinoma, gallbladder carcinoma, intestine carcinoma in situ, gastric carcinoma, exocrine pancreatic carcinoma, small intestine carcinoma, pancreatic endocrine carcinoma, ameloblastic carcinoma, carcinoma of liver and intrahepatic biliary tract, carcinoma of esophagus, carcinoma of floor of mouth, carcinoma of pharynx, colorectal carcinoma, oral cavity carcinoma

Subtypes (1): pancreatic carcinoma with mixed differentiation

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.